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In the short time since its elucidation, RNA inter-
ference (RNAi) has quickly emerged as the premier
tool in which to study gene function. RNAi pro-
vides a simple and predictable yet extremely pow-
erful and speciﬁc method in which to knock down
gene expression in virtually any cell type or whole
organism. The major advance in RNAi technology,
particularly for mammalian systems, came with
the discovery that small 21–25 nt RNA duplexes,
termed ‘short interfering RNAs’ (siRNAs), mediate
the gene-silencing effect. The ability to efﬁciently
deliver silencing duplexes into cells using in vitro
synthesized RNAs or through DNA-based expres-
sion constructs coupled with the ability to predict
effective siRNA guide sequences in silico makes
RNAi a powerful tool for systematic, genome-
wide analysis of gene function. The potential of
RNAi to completely revolutionize the study of gene
function led to it being named ‘Breakthrough of
the Year 2002’ by Science. RNAi-mediated gene
silencing has proved to be both potent and highly
speciﬁc; however, careful consideration of siRNA
sequence design and experimental conditions must
be taken, so that off-target effects and, in the case
of mammalian systems, interferon responses are
minimized. The rapid development and widespread
adoption of RNAi technology means that this latest
book in the in practice series could be a welcome
addition to a lab’s manuals.
The book is divided into four chapters and
begins with a comprehensive introduction deﬁning
the concepts and current knowledge regarding
the molecular mechanisms of RNAi. This chapter
is sub-sectioned according to pertinent questions,
such as ‘miRNAs versus siRNA: two classes of
small RNAs using the RNAi pathway?’, and when
appropriate also tries to explain differences in
mechanism of RNAi between species. It is up-to-
date and is well referenced for those who would
like further reading.
The remaining three chapters comprise the bulk
of the book and are arranged by organism of study;
Caenorhabditis elegans, Drosophila and mammals.
The chapters on C. elegans and Drosophila are rea-
sonably concise at around 40 pages each, whereas
the mammal chapter is over 130 pages long, reﬂect-
ing the additional complexity when silencing mam-
malian genes. Although each chapter focuses on
methods speciﬁc to that organism, some protocols
are universal, e.g. making siRNAs by in vitro tran-
scription is described in the C. elegans chapter
but these duplexes can also be used in Drosophila
and mammalian cells. Each of these chapters starts
with a brief introduction and is followed by an
applications note, then systematically covers spe-
ciﬁc methods and protocols. Each protocol is very
detailed, with step-by-step instructions and help-
ful technical tips or notes added in places. A list
of abbreviations and a glossary of terms is also
provided in the appendices. A small number of
the molecular biology protocols provided are very
generic, e.g. the pouring of PAGE gels, and will not
be of much use to those already proﬁcient in such
applications. In addition, it is unlikely that a single
lab will be using RNAi in all the organisms men-
tioned, so some chapters of the book may not be
that relevant. However, each chapter is rich in tech-
nical detail and points to external sources of further
information when appropriate, making this a useful
introduction for those starting work on a particular
organism for the ﬁrst time. This book could also
be used effectively as a general lab manual, as it
covers a wide range of common methods in detail.
Chapter 2 focuses on gene silencing methods in
the nematode worm C. elegans, a system which is
very amenable to RNAi-mediated reverse genet-
ics and useful for genome-wide screening. Pro-
tocols for in vitro transcription from T7/SP6/T3
promoter-driven DNA plasmid templates or by
PCR using T7 promoter-linked primers to create
RNA duplexes for silencing is covered here. Help-
fully, the chapter also provides a short course in
basic worm anatomy, propagation and microinjec-
tion techniques, as well as recommending worm
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strains for experiments. Methods for introducing
silencing RNA duplexes into worms are reason-
ably straightforward; protocols for RNA soaking
and feeding them on E. coli that are engineered to
express dsRNA or hairpin RNAs are provided. The
design and creation of both dsRNA- and hairpin
RNA-expressing plasmids are described in length.
Finally, the chapter closes with a brief section
about genome-wide screens and suggests on-line
resources for RNAi libraries.
Chapter 3 describes silencing in the fruit ﬂy,
Drosophila, a system traditionally useful for devel-
opmental studies. It starts by covering the appli-
cations and experimental possibilities of silenc-
ing in both Drosophila cell lines and adult ﬂies.
Basic methods for the creation of RNA duplexes
and hairpin-RNA expression constructs, similar in
principle to those for C. elegans, are described.
Drosophila studies often involve the GAL4–UAS
binary expression system to allow inducible and
tissue-speciﬁc gene expression and their adapta-
tion for use in gene silencing experiments is com-
prehensively covered. A useful table listing the
advantages and disadvantages of using exogenous
RNA duplexes vs. endogenously expressed hairpin-
RNAs is given here and it will help in choosing
the correct silencing method for your particular
application. Detailed protocols for all the silenc-
ing methods mentioned are available but additional
protocols for working with Drosophila S2 cells, as
well as embryos for creation of ﬂies, are also given.
Like the previous chapter, this one ﬁnishes by
brieﬂy considering high-throughput RNAi screens
and useful on-line sources of information.
Chapter 4 deals with RNAi-mediated gene silenc-
ing in mammalian systems. It is the longest chapter
by far and provides a wealth of genuinely use-
ful information on the molecular mechanisms of
RNAi in addition to a comprehensive set of pro-
tocols. Unlike C. elegans or Drosophila, which
typically use long RNA duplexes, RNAi-mediated
silencing in mammals is normally achieved through
the use of short 21–23 nt RNA duplexes, the rea-
son for this being that mammals possess powerful
antiviral or interferon-like defence pathways that
become activated in response to longer double-
stranded RNA and lead to global inhibition of
translation and cell death. The chapter starts by
explaining these facts and brieﬂy describes how
these problems were circumvented by the discov-
ery that RNAi pathways are active in mammalian
cells and that the interferon-like response can be
bypassed by utilizing short RNA duplexes. The
introduction of these short RNAs into mammalian
cells can be done by a large variety of meth-
ods, from exogenously supplied, chemically syn-
thesized siRNAs through to the expression of short-
hairpin RNA (shRNA) from DNA-based plasmid
or viral vectors. Each silencing approach, along
with its variations, is systematically covered and
the pros and cons of each method are clearly
stated. Transient silencing methods utilizing siR-
NAs are dealt with ﬁrst. Chemically synthesized
siRNAs are widely used in gene silencing exper-
iments and a brief overview of RNA chemistry
and synthesis is given, although no protocols are
provided. This is sensible, as most labs will not
have access to the specialized RNA technologies
that are required and siRNAs are now relatively
inexpensive and widely available to buy. One key
factor in successful siRNA silencing experiments
is the target sequence used. The design criteria for
siRNAs is very well explained and a step-by-step
protocol for manually ﬁnding optimal siRNA tar-
geting sequences is given, along with advice on
how to perform homology searches for speciﬁcity.
Free on-line design algorithms and companies that
chemically synthesize siRNAs are also mentioned.
It may be worth mentioning that siRNA design
algorithms have now advanced to the point where
most siRNA suppliers offer guarantees that their
siRNAs will be effective, making manual designs,
for most applications, unnecessary.
In a similar fashion to that described for C. ele-
gans and Drosophila, siRNAs can be enzymati-
cally produced through in vitro transcription reac-
tions. Protocols are provided to create siRNAs from
in vitro transcription reactions with T7 promoter-
driven DNA oligos, as well as from Dicer- or
RNase III-mediated digestion of long dsRNAs.
Methods for the expression and puriﬁcation of
recombinant Dicer from baculovirus and RNase III
in E. coli are also generously provided, although
these enzymes can now be bought commercially.
Efﬁcient delivery of siRNAs into cells is another
key factor for successful gene silencing. Rather
than providing an exhaustive set of transfection
methods, a single protocol using a common ref-
erence procedure is instead supplied. Given the
ever-increasing number of lipid-based transfection
reagents available and the large number of differ-
ent cell types, the reader is sensibly directed to
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look at the suppliers’ websites for further informa-
tion and cell type-speciﬁc protocols. Transfection
methods using the lipid-based Lipofectamine-2000
reagent and a generic electroporation protocol are
described. A less well-known method of siRNA
delivery is through the chemical coupling of siR-
NAs to cell penetration peptides (CPPs) such as
Penetratin or HIV TAT sequences. Although trans-
fection and electroporation methods of delivery are
sufﬁcient for cells in culture, they are not applicable
for clinical applications and therefore CPP-coupled
siRNAs may offer a solution to this problem. Meth-
ods for the chemical modiﬁcation of siRNAs, cou-
pling to CPPs and delivery into cells are all given.
A small set of protocols for analysis of siRNAs by
PAGE or agarose-gel electrophoresis ﬁnishes off
the section about siRNAs.
Gene silencing can be also accomplished by the
endogenous expression of shRNAs from DNA-
based vectors. The concept and design of shRNAs
are described here and methods are again based
on commonly used expression systems rather than
listing them all. A number of detailed methods
are provided, covering RNA PolIII promoter selec-
tion, oligonucleotide cloning into DNA expression
plasmids (pSUPER vectors) and the cloning, pro-
duction and titration of retroviral vectors (pLentilox
system). Adenoviral delivery systems are not cov-
ered. Inducible shRNA expression systems based
on the tetracycline operon are discussed but no
speciﬁc methods are given; instead the reader is
directed to look at primary research papers. The
application of RNAi silencing in mice provides
another small section of discussion and methods
focus on the delivery to whole mice and ES cells
or oocytes. Again, the reader is referred to primary
research papers for more detail.
Although the use of short RNA duplexes effec-
tively avoids the interferon response, long hairpin
RNAs (lhRNAs), similar to those typically used
for C. elegans and Drosophila studies, have been
found to be able to elicit an RNAi-silencing effect
in some mammalian cell types. The pros and cons
of using lhRNAs are deﬁned and an in-depth series
of methods follow, describing the construction of
lhRNA expression plasmids using inverted repeat
and direct repeat DNAs. One problem with lhRNA
cloning is the high chance of recombination, and a
list of suitable E. coli cloning strains is supplied,
along with a high-throughput method to screen for
full-length clones. Another problem is the possibil-
ity of interferon responses and a number of proto-
cols are supplied with which this response can be
monitored.
Like the previous chapters, discussion of RNAi
in mammals ﬁnishes with a section on high-
throughput silencing screens. Previously described
genome-wide RNAi initiatives are discussed, with
particular attention to shRNA library construction
and bar-coding to identify each shRNA. RNAi
microarrays are also mentioned, in which slides
are imprinted with siRNA or shRNAs and cells
reverse-transfected onto it. Here, the focus is
clearly on shRNA-derived libraries and siRNA-
derived libraries are only very brieﬂy mentioned.
The experimental considerations for actually per-
forming library screens are not really discussed.
The book ends with a number of appendices
with lists of abbreviations, protocols, RNAi reagent
suppliers and an excellent glossary of terms. One
minor gripe is that the appendix containing the
list of protocols does not show the page numbers
on which they are contained, therefore limiting its
usefulness as a quick reference.
The phenomenon of RNAi-mediated ‘silencing’
of gene expression has become a powerful tool in
the analysis of gene function and this text provides
an excellent source of reference information for
both experienced and novice users alike. I would
recommend this book to anyone wishing to estab-
lish RNAi-mediated gene silencing in their lab.
Alan Lau
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